These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34030153)

  • 21. HIV pre-exposure prophylaxis and diagnoses of sexually transmitted infections - observational data from German checkpoints, 01/2019-08/2021.
    Marcus U; Schink SB; Weber C
    BMC Public Health; 2023 Apr; 23(1):661. PubMed ID: 37029369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection.
    Traeger MW; Cornelisse VJ; Asselin J; Price B; Roth NJ; Willcox J; Tee BK; Fairley CK; Chang CC; Armishaw J; Vujovic O; Penn M; Cundill P; Forgan-Smith G; Gall J; Pickett C; Lal L; Mak A; Spelman TD; Nguyen L; Murphy DA; Ryan KE; El-Hayek C; West M; Ruth S; Batrouney C; Lockwood JT; Hoy JF; Hellard ME; Stoové MA; Wright EJ;
    JAMA; 2019 Apr; 321(14):1380-1390. PubMed ID: 30964528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methods for county-level estimation of pre-exposure prophylaxis coverage and application to the U.S. Ending the HIV Epidemic jurisdictions.
    Sullivan PS; Mouhanna F; Mera R; Pembleton E; Castel AD; Jaggi C; Jones J; Kramer MR; McGuinness P; McCallister S; Siegler AJ
    Ann Epidemiol; 2020 Apr; 44():16-30. PubMed ID: 32088073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Missed opportunities for sexually transmitted infections testing for HIV pre-exposure prophylaxis users: a systematic review.
    Ong JJ; Fu H; Baggaley RC; Wi TE; Tucker JD; Smith MK; Rafael S; Falconer J; Terris-Prestholt F; Mameletzis I; Mayaud P
    J Int AIDS Soc; 2021 Feb; 24(2):e25673. PubMed ID: 33605081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence and Correlates of Sexually Transmitted Infections Among Black Men Who Have Sex With Men Participating in the HIV Prevention Trials Network 073 Preexposure Prophylaxis Study.
    Hightow-Weidman LB; Magnus M; Beauchamp G; Hurt CB; Shoptaw S; Emel L; Piwowar-Manning E; Mayer KH; Nelson LE; Wilton L; Watkins P; Whitfield D; Fields SD; Wheeler D
    Clin Infect Dis; 2019 Oct; 69(9):1597-1604. PubMed ID: 30615169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in Human Immunodeficiency Virus and Sexually Transmitted Infection Testing Among Gay, Bisexual, and Other Men Who Have Sex With Men After Rapid Scale-up of Preexposure Prophylaxis in Victoria, Australia.
    Ryan KE; Asselin J; Fairley CK; Armishaw J; Lal L; Nguyen L; Murphy D; Traeger M; Hellard M; Hoy J; Stoové M; Wright E;
    Sex Transm Dis; 2020 Aug; 47(8):516-524. PubMed ID: 32658175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preexposure Prophylaxis Outcomes in an Urban Community in North Carolina: Discontinuation of Care and Sexually Transmitted Infections.
    Clement ME; Nicchitta M; Sun Y; Ellis A; Chakraborty H; McGee K; Eagle C; Frye J; Taylor D; Okeke NL; Johnston B; Seña AC; McKellar M
    Sex Transm Dis; 2021 Mar; 48(3):183-188. PubMed ID: 33003182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Examination of Incidence of Sexually Transmitted Infections in the Ending the HIV Epidemic Priority Counties of the United States, 2005-2019.
    Bunting SR; Hunt B; Johnson AK; Hazra A; Nunez-Garcia A; Glick N
    Sex Transm Dis; 2024 Mar; 51(3):139-145. PubMed ID: 38100791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incident Cases of Sexually Transmitted Infections among Users of Pre-Exposure Prophylaxis for HIV Prevention in Honolulu, Hawai'i.
    Kiefer EM; Ross KS; Santos AC; Barney MR; McCormick TJ; Chow DC; Shikuma CM
    Hawaii J Health Soc Welf; 2021 Jul; 80(7):148-154. PubMed ID: 34278321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beyond Disease Intervention: Exploring an Expanded Role for Partner Services in the MATRix-NC Demonstration Project.
    Hurt CB; Morrison AS; Guy J; Mobley VL; Dennis AM; Barrington C; Samoff E; Hightow-Weidman LB; McNeil CJ; Carry MG; Hogben M; Seña AC
    Sex Transm Dis; 2022 Feb; 49(2):93-98. PubMed ID: 34475364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient Disengagement From an HIV Preexposure Prophylaxis Program in a Sexually Transmitted Disease Clinic.
    Dombrowski JC; Golden MR; Barbee LA; Khosropour CM
    Sex Transm Dis; 2018 Sep; 45(9):e62-e64. PubMed ID: 29485544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discussion and Initiation of HIV Pre-exposure Prophylaxis Were Rare Following Diagnoses of Sexually Transmitted Infections Among Veterans.
    Kobayashi T; Van Epps P; Maier MM; Beste LA; Beck BF; Alexander B; Ohl ME
    J Gen Intern Med; 2022 Aug; 37(10):2482-2488. PubMed ID: 34341917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Doxycycline post-exposure prophylaxis for prevention of sexually transmitted infections among Kenyan women using HIV pre-exposure prophylaxis: study protocol for an open-label randomized trial.
    Stewart J; Bukusi E; Sesay FA; Oware K; Donnell D; Soge OO; Celum C; Odoyo J; Kwena ZA; Scoville CW; Violette LR; Morrison S; Simoni J; McClelland RS; Barnabas R; Gandhi M; Baeten JM
    Trials; 2022 Jun; 23(1):495. PubMed ID: 35710444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. U.S. Black Women and Human Immunodeficiency Virus Preexposure Prophylaxis Implementation.
    Hoover KW; Kourtis AP; Smith DK
    Obstet Gynecol; 2022 Jul; 140(1):106-109. PubMed ID: 35849466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prophylactic use of antibiotics for sexually transmitted infections: awareness and use among HIV PrEP users in Belgium.
    Vanbaelen T; Reyniers T; Rotsaert A; Vuylsteke B; Florence E; Kenyon C; De Baetselier I
    Sex Transm Infect; 2022 Dec; 98(8):625. PubMed ID: 35896415
    [No Abstract]   [Full Text] [Related]  

  • 36. Missed Opportunities for HIV Testing and PrEP Education in a High-risk Population at a Safety-net Health Care System.
    Shipton L; Ue F; Seufert T; Marvin C
    J Health Care Poor Underserved; 2023; 34(1):102-111. PubMed ID: 37464483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Facing increased sexually transmitted infection incidence in HIV preexposure prophylaxis cohorts: what are the underlying determinants and what can be done?
    Kenyon C; Van Dijck C; Florence E
    Curr Opin Infect Dis; 2020 Feb; 33(1):51-58. PubMed ID: 31789694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gaps in Sexually Transmitted Infection Screening Among Men who Have Sex with Men in Pre-exposure Prophylaxis (PrEP) Care in the United States.
    Chandra C; Weiss KM; Kelley CF; Marcus JL; Jenness SM
    Clin Infect Dis; 2021 Oct; 73(7):e2261-e2269. PubMed ID: 32702116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. America's HIV Epidemic Analysis Dashboard: Protocol for a Data Resource to Support Ending the HIV Epidemic in the United States.
    Sullivan PS; Woodyatt CR; Kouzouian O; Parrish KJ; Taussig J; Conlan C; Phillips H
    JMIR Public Health Surveill; 2022 Feb; 8(2):e33522. PubMed ID: 35142639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Availability of Safety-net Sexually Transmitted Disease Clinical Services in the U.S., 2018.
    Leichliter JS; O'Donnell K; Kelley K; Cuffe KM; Weiss G; Gift TL
    Am J Prev Med; 2020 Apr; 58(4):555-561. PubMed ID: 32001050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.